Search research articles
Contact Us
Filters
Showing results (151-160 of 751) with videos related to
Page
of 76
Sort By:
Urology
|
November 1, 1987
Effective long-term suppression of pituitary-gonadal axis in prostatic cancer by Zoladex (ICI 118,630)
G P Murphy, J Greco, R Huben
International Advances in Surgical Oncology
|
January 1, 1982
Recent patterns of care of prostate cancer patients in the United States: results from the surveys of the American college of Surgeons Commission on Cancer
C Mettlin, N Natarajan, G P Murphy
Journal of the National Cancer Institute
|
October 1, 1972
Carcinogenicity of ethylmethanesulfonate
W Hrushesky, D Sampson, G P Murphy
Journal of Surgical Oncology
|
January 1, 1972
The effect of androgen on canine prostatic secretion
R Schoonees, G Reynoso, G P Murphy
Archives of Surgery (Chicago, Ill. : 1960)
|
September 1, 1972
Lymphocyturia in human renal allograft rejection
W Hrushesky, D Sampson, G P Murphy
Oncology
|
January 1, 1978
A study of the effect of papaverine in neuroblastoma using the experimental C1300 murine system
Z Wajsman, P Williams, G P Murphy
International Journal of Cancer
|
January 2, 1994
UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Geneva, 29 September-1 October 1993
S Eckhardt, F Badellino, G P Murphy
Investigative Urology
|
March 1, 1979
Chalones and stroma as possible growth-limiting factors in the rat ventral prostate
J Müntzing, J Liljekvist, G P Murphy
Cancer Chemotherapy Reports
|
June 1, 1972
Initial clinical study of tris(2,2-dimethyl-1-aziridinyl)phosphine oxide (TEPA-132)
A Mittelman, J Plager, G P Murphy
Research Communications in Chemical Pathology and Pharmacology
|
March 1, 1981
Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model
P D Williams, P Kantor, G P Murphy
Page
of 76
Search research articles
Search
Showing results (151-160 of 751) with videos related to
Sort By:
Page
of 76
Urology
|
November 1, 1987
Effective long-term suppression of pituitary-gonadal axis in prostatic cancer by Zoladex (ICI 118,630)
G P Murphy, J Greco, R Huben
International Advances in Surgical Oncology
|
January 1, 1982
Recent patterns of care of prostate cancer patients in the United States: results from the surveys of the American college of Surgeons Commission on Cancer
C Mettlin, N Natarajan, G P Murphy
Journal of the National Cancer Institute
|
October 1, 1972
Carcinogenicity of ethylmethanesulfonate
W Hrushesky, D Sampson, G P Murphy
Journal of Surgical Oncology
|
January 1, 1972
The effect of androgen on canine prostatic secretion
R Schoonees, G Reynoso, G P Murphy
Archives of Surgery (Chicago, Ill. : 1960)
|
September 1, 1972
Lymphocyturia in human renal allograft rejection
W Hrushesky, D Sampson, G P Murphy
Oncology
|
January 1, 1978
A study of the effect of papaverine in neuroblastoma using the experimental C1300 murine system
Z Wajsman, P Williams, G P Murphy
International Journal of Cancer
|
January 2, 1994
UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Geneva, 29 September-1 October 1993
S Eckhardt, F Badellino, G P Murphy
Investigative Urology
|
March 1, 1979
Chalones and stroma as possible growth-limiting factors in the rat ventral prostate
J Müntzing, J Liljekvist, G P Murphy
Cancer Chemotherapy Reports
|
June 1, 1972
Initial clinical study of tris(2,2-dimethyl-1-aziridinyl)phosphine oxide (TEPA-132)
A Mittelman, J Plager, G P Murphy
Research Communications in Chemical Pathology and Pharmacology
|
March 1, 1981
Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model
P D Williams, P Kantor, G P Murphy
Page
of 76